Your cart is empty.
Your cart is empty.
Research-grade peptide compounds supplied for in vitro investigation of anabolic signaling pathways, myogenic differentiation, and receptor pharmacology models.
A synthetic GHRH analog studied for receptor binding kinetics, molecular interaction modeling, and pulsatile signaling pathway investigation in preclinical settings.
Research-grade synthetic GHRH analog peptide formulated with Drug Affinity Complex for extended-duration peptide stability studies and modified peptide characterization research in controlled laboratory environments.
High-purity research peptide supplied for controlled laboratory studies with verified DAC conjugation stability and sequence authentication. CJC-1295 (10mg) is a modified peptide engineered with a Drug Affinity Complex component. A...
Research-grade peptide analogue supplied in a 5mg format for controlled investigation of growth hormone releasing hormone receptor (GHRH-R) interaction and signaling pathways.
Research-grade dual-peptide blend combining short-acting synthetic peptides for flexible laboratory research protocols.
Follistatin 344 1mg – Activin-Binding Glycoprotein for Preclinical TGF-β Superfamily Signaling Pharmacology, Activin Receptor Ligand Interaction Kinetics, and Myostatin Pathway Inhibition Research A structurally defined synthetic follistatin isoform glycoprotein studied...
Research-grade synthetic hexapeptide supplied in a 5mg format for controlled in vitro investigation of growth hormone secretagogue receptor (GHS-R1a) signaling pathways.
Research-grade synthetic hexapeptide supplied in a 10mg format for controlled in vitro investigation of GHS-R1a receptor binding and intracellular signaling assays.
Research-grade synthetic hexapeptide supplied in a 5mg format for controlled in vitro investigation of growth hormone secretagogue receptor (GHS-R1a) interaction and peptide signaling models.
Research-grade synthetic hexapeptide supplied in a 10mg format for controlled in vitro investigation of growth hormone secretagogue receptor (GHS-R1a) interaction and peptide signaling models.
Hexarelin 5mg – Ultra-Potent GHRP for Preclinical GH Secretagogue Pharmacology, CD36 Receptor Binding Kinetics, and Cardiovascular Signaling Pathway Research A high-potency synthetic hexapeptide growth hormone releasing peptide studied for maximal...
Research-grade recombinant protein hormone formulated in 10IU quantity for protein structure characterization and recombinant hormone analytical studies in controlled laboratory environments.
Primary experimental domains include:
All research contexts are mechanistic and cell-based.
Store lyophilized materials at -20°C in desiccated conditions.
Reconstitute under sterile laboratory conditions appropriate to the assay system.
Avoid repeated freeze-thaw cycles.
Endotoxin-controlled handling is recommended for primary myoblast cultures.
Documentation includes:
Compounds are designated strictly as research-use biochemicals.
Includes:
No. They are supplied exclusively for in vitro research.
C2C12 myoblasts, primary myoblasts, somatotroph models, and receptor-overexpression systems.
Yes, particularly for differentiation and satellite cell assays.
This website contains information on research compounds intended for laboratory use only. You must be 21 years or older to enter and view this content. By entering, you also agree that all products are for research use only and are not intended for human consumption.